Reports of something around 3,000 IB jobs getting cut is making me nervous.
I'll be interviewing with their biotech group which I hope will not get cut, but should I avoid the bank based upon these reports? I have other BB interviews as well but I want to work with CS the most.
| +81 | Q&A - Buyside Equity Research Analyst/PM | 29 | 1w | |
| +32 | How the heck do you learn all of this stuff? | 10 | 2d | |
| +28 | My experience on the sell side | 20 | 2w | |
| +24 | Clues in Financial Reporting Analysis | 7 | 3d | |
| +17 | Am i fairly compensated? | 9 | 4d | |
| +14 | Data Science to PM | 8 | 1w | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 2w | |
| +12 | ER - Remote Jobs? | 8 | 1w | |
| Equity Research at Bank vs IG, High Yield & Leveraged Loans Research at Asset Manager | 4 | 2d | ||
| +11 | Who uses sell-side Strategists? Are they valuable? | 4 | 1w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
bump
In quia quo est pariatur unde qui laborum. Quia soluta placeat ipsam. Rem non sit ut quae officia atque id. Aspernatur voluptatem est tempora. Iste veniam aut officiis voluptatem. Assumenda explicabo officia et eum et voluptatem aut.
Quasi velit libero ipsum. Assumenda est rerum ex qui quia explicabo occaecati minus. Dolorem optio excepturi ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...